Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04938804

Non-risk Based Lang Cancer Screening With a One-off LDCT

Non-risk Based Lung Cancer Screening With One-time Low-dose Computed Tomography: a Prospective Cohort Study

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
11,000 (estimated)
Sponsor
The First Affiliated Hospital of Guangzhou Medical University · Academic / Other
Sex
All
Age
40 Years – 74 Years
Healthy volunteers
Accepted

Summary

Guangzhou Lung-Care Project is a single-arm, prospective cohort study using one-time low-dose computed tomography for the early detection of LC, recruiting residents aged 40-74 years from four communities in Guangzhou between 2015 and 2021.The primary outcome was LC detection rate in eligible participants without restrictions based on high-risk factors and the proportion of stage I LC cases, and to investigate the various factors associated with the development of LC.

Detailed description

Guangzhou Lung-Care Project is a single-arm, prospective cohort study using one-time low-dose computed tomography for the early detection of LC, recruiting residents aged 40-74 years from four communities in Guangzhou between 2015 and 2021. Follow-up for post-screening management and survival was recorded. The primary outcome was LC detection rate in eligible participants without restrictions based on high-risk factors and the proportion of stage I LC cases, and to investigate the various factors associated with the development of LC. Additionally, we compared the detection rates of LC and the proportion of stage I LC cases between "high-risk" and "non-high-risk" groups according to the National Comprehensive Cancer Network (NCCN) guidelines and Chinese guideline.

Conditions

Interventions

TypeNameDescription
DEVICELow-dose computed tomographyThe Low-dose computed tomography is conducted according to the guideline suggested by American College of Radiology.

Timeline

Start date
2015-12-12
Primary completion
2025-12-01
Completion
2026-12-01
First posted
2021-06-24
Last updated
2024-01-09

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04938804. Inclusion in this directory is not an endorsement.